25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Sangui Biotech International Inc
Buy, Hold or Sell?

Let's analyze Sangui Biotech International Inc together

I guess you are interested in Sangui Biotech International Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sangui Biotech International Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sangui Biotech International Inc

I send you an email if I find something interesting about Sangui Biotech International Inc.

1. Quick Overview

1.1. Quick analysis of Sangui Biotech International Inc (30 sec.)










1.2. What can you expect buying and holding a share of Sangui Biotech International Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-0.01
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-181.2%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0015 - $0.0015
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sangui Biotech International Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.01
Total Value Per Share
$-0.01 - $0.01

2.2. Growth of Sangui Biotech International Inc (5 min.)




Is Sangui Biotech International Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1m-$894.9k-$142.9k-13.8%

How much money is Sangui Biotech International Inc making?

Current yearPrevious yearGrowGrow %
Making money-$147.7k$16.7k-$164.5k-111.4%
Net Profit Margin-158.8%24.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Sangui Biotech International Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sangui Biotech International Inc?

Welcome investor! Sangui Biotech International Inc's management wants to use your money to grow the business. In return you get a share of Sangui Biotech International Inc.

First you should know what it really means to hold a share of Sangui Biotech International Inc. And how you can make/lose money.

Speculation

The Price per Share of Sangui Biotech International Inc is $0.0015. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sangui Biotech International Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sangui Biotech International Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sangui Biotech International Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-46.9%0.00-46.9%0.00-18.8%0.00-58.6%0.00-126.7%
Usd Book Value Change Per Share0.00-45.3%0.00-45.3%0.00-6.2%0.00-43.6%0.00-42.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-45.3%0.00-45.3%0.00-6.2%0.00-43.6%0.00-42.4%
Usd Price Per Share0.00-0.00-0.01-0.01-0.02-
Price to Earnings Ratio-4.97--4.97--35.39--17.70--14.31-
Price-to-Total Gains Ratio-5.15--5.15--106.92--35.63--93.92-
Price to Book Ratio-0.71--0.71--2.35--3.50--8.85-
Price-to-Total Gains Ratio-5.15--5.15--106.92--35.63--93.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0015
Number of shares666666
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (666666 shares)-453.08-436.06
Gains per Year (666666 shares)-1,812.32-1,744.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1812-18220-1744-1754
20-3625-36340-3488-3498
30-5437-54460-5233-5242
40-7249-72580-6977-6986
50-9062-90700-8721-8730
60-10874-108820-10465-10474
70-12686-126940-12210-12218
80-14499-145060-13954-13962
90-16311-163180-15698-15706
100-18123-181300-17442-17450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.024.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%6.016.02.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.024.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%6.016.02.025.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sangui Biotech International Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.000-86%-0.001-4%-0.001-6%
Book Value Per Share---0.005-0.0050%-0.004-14%-0.004-20%-0.003-49%
Current Ratio--0.0390.0390%0.072-46%0.072-45%0.234-83%
Debt To Asset Ratio--12.41312.4130%7.843+58%8.620+44%5.932+109%
Debt To Equity Ratio----0%-0%2.727-100%1.993-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.0010%0.000-60%-0.001+25%-0.002+170%
Free Cash Flow Per Share--0.0000.0000%-0.001+1107%-0.001+1252%-0.001+2582%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-718%0.000-1668%0.000-426%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.028-3%
Intrinsic Value_10Y_max--0.014--------
Intrinsic Value_10Y_min---0.002--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max--0.001--------
Intrinsic Value_3Y_min---0.003--------
Intrinsic Value_5Y_max--0.003--------
Intrinsic Value_5Y_min---0.003--------
Market Cap314853.000-133%734844.593734844.5930%2099020.000-65%2690981.159-73%3570451.779-79%
Net Profit Margin---1.588-1.5880%0.243-754%-3.222+103%-4.832+204%
Operating Margin---0.947-0.9470%-0.552-42%-2.783+194%-6.132+548%
Operating Ratio--1.9471.9470%3.015-35%4.075-52%5.604-65%
Pb Ratio-0.303+57%-0.708-0.7080%-2.345+231%-3.499+394%-8.850+1150%
Pe Ratio-2.132+57%-4.975-4.9750%-35.391+611%-17.704+256%-14.305+188%
Price Per Share0.002-133%0.0040.0040%0.010-65%0.013-73%0.017-79%
Price To Free Cash Flow Ratio-27.058+57%-63.136-63.1360%-14.944-76%-27.370-57%-19.031-70%
Price To Total Gains Ratio-2.207+57%-5.150-5.1500%-106.918+1976%-35.634+592%-93.924+1724%
Quick Ratio--0.0290.0290%0.047-39%0.056-49%0.172-83%
Return On Assets---1.624-1.6240%0.128-1365%-1.802+11%-2.936+81%
Return On Equity----0%-0%-1.2880%-1.5230%
Total Gains Per Share---0.001-0.0010%0.000-86%-0.001-4%-0.001-6%
Usd Book Value---1037876.000-1037876.0000%-894957.000-14%-826005.000-20%-532181.600-49%
Usd Book Value Change Per Share---0.001-0.0010%0.000-86%-0.001-4%-0.001-6%
Usd Book Value Per Share---0.005-0.0050%-0.004-14%-0.004-20%-0.003-49%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.0010%0.000-60%-0.001+25%-0.002+170%
Usd Free Cash Flow---11639.000-11639.0000%-140456.000+1107%-157268.800+1251%-312049.000+2581%
Usd Free Cash Flow Per Share--0.0000.0000%-0.001+1107%-0.001+1252%-0.001+2582%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-718%0.000-1668%0.000-426%
Usd Market Cap314853.000-133%734844.593734844.5930%2099020.000-65%2690981.159-73%3570451.779-79%
Usd Price Per Share0.002-133%0.0040.0040%0.010-65%0.013-73%0.017-79%
Usd Profit---147721.000-147721.0000%16794.000-980%-180483.400+22%-396894.500+169%
Usd Revenue--93039.00093039.0000%69190.000+34%68946.000+35%79848.300+17%
Usd Total Gains Per Share---0.001-0.0010%0.000-86%-0.001-4%-0.001-6%
 EOD+2 -6MRQTTM+0 -0YOY+8 -235Y+15 -1710Y+15 -18

3.3 Fundamental Score

Let's check the fundamental score of Sangui Biotech International Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.132
Price to Book Ratio (EOD)Between0-1-0.303
Net Profit Margin (MRQ)Greater than0-1.588
Operating Margin (MRQ)Greater than0-0.947
Quick Ratio (MRQ)Greater than10.029
Current Ratio (MRQ)Greater than10.039
Debt to Asset Ratio (MRQ)Less than112.413
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.624
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Sangui Biotech International Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.002
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Sangui Biotech International Inc

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

Fundamental data was last updated by Penke on 2024-11-23 22:46:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sangui Biotech International Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sangui Biotech International Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -158.8% means that $-1.59 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sangui Biotech International Inc:

  • The MRQ is -158.8%. The company is making a huge loss. -2
  • The TTM is -158.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-158.8%TTM-158.8%0.0%
TTM-158.8%YOY24.3%-183.0%
TTM-158.8%5Y-322.2%+163.4%
5Y-322.2%10Y-483.2%+161.0%
4.3.1.2. Return on Assets

Shows how efficient Sangui Biotech International Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sangui Biotech International Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -162.4% Return on Assets means that Sangui Biotech International Inc generated $-1.62 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sangui Biotech International Inc:

  • The MRQ is -162.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -162.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-162.4%TTM-162.4%0.0%
TTM-162.4%YOY12.8%-175.3%
TTM-162.4%5Y-180.2%+17.8%
5Y-180.2%10Y-293.6%+113.4%
4.3.1.3. Return on Equity

Shows how efficient Sangui Biotech International Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sangui Biotech International Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Sangui Biotech International Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sangui Biotech International Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-128.8%+128.8%
5Y-128.8%10Y-152.3%+23.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sangui Biotech International Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sangui Biotech International Inc is operating .

  • Measures how much profit Sangui Biotech International Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sangui Biotech International Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -94.7% means the company generated $-0.95  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sangui Biotech International Inc:

  • The MRQ is -94.7%. The company is operating very inefficient. -2
  • The TTM is -94.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-94.7%TTM-94.7%0.0%
TTM-94.7%YOY-55.2%-39.5%
TTM-94.7%5Y-278.3%+183.6%
5Y-278.3%10Y-613.2%+335.0%
4.3.2.2. Operating Ratio

Measures how efficient Sangui Biotech International Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.95 means that the operating costs are $1.95 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sangui Biotech International Inc:

  • The MRQ is 1.947. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.947. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.947TTM1.9470.000
TTM1.947YOY3.015-1.069
TTM1.9475Y4.075-2.129
5Y4.07510Y5.604-1.529
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sangui Biotech International Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sangui Biotech International Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.04 means the company has $0.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sangui Biotech International Inc:

  • The MRQ is 0.039. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.039. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.039TTM0.0390.000
TTM0.039YOY0.072-0.033
TTM0.0395Y0.072-0.033
5Y0.07210Y0.234-0.162
4.4.3.2. Quick Ratio

Measures if Sangui Biotech International Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sangui Biotech International Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.03 means the company can pay off $0.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sangui Biotech International Inc:

  • The MRQ is 0.029. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.029. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.029TTM0.0290.000
TTM0.029YOY0.047-0.018
TTM0.0295Y0.056-0.028
5Y0.05610Y0.172-0.116
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sangui Biotech International Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sangui Biotech International Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sangui Biotech International Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 12.41 means that Sangui Biotech International Inc assets are financed with 1,241.3% credit (debt) and the remaining percentage (100% - 1,241.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sangui Biotech International Inc:

  • The MRQ is 12.413. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 12.413. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ12.413TTM12.4130.000
TTM12.413YOY7.843+4.570
TTM12.4135Y8.620+3.793
5Y8.62010Y5.932+2.689
4.5.4.2. Debt to Equity Ratio

Measures if Sangui Biotech International Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sangui Biotech International Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sangui Biotech International Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.727-2.727
5Y2.72710Y1.993+0.734
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sangui Biotech International Inc generates.

  • Above 15 is considered overpriced but always compare Sangui Biotech International Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.97 means the investor is paying $-4.97 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sangui Biotech International Inc:

  • The EOD is -2.132. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.975. Based on the earnings, the company is expensive. -2
  • The TTM is -4.975. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.132MRQ-4.975+2.843
MRQ-4.975TTM-4.9750.000
TTM-4.975YOY-35.391+30.416
TTM-4.9755Y-17.704+12.729
5Y-17.70410Y-14.305-3.399
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sangui Biotech International Inc:

  • The EOD is -27.058. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -63.136. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -63.136. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-27.058MRQ-63.136+36.078
MRQ-63.136TTM-63.1360.000
TTM-63.136YOY-14.944-48.192
TTM-63.1365Y-27.370-35.766
5Y-27.37010Y-19.031-8.339
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sangui Biotech International Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Sangui Biotech International Inc:

  • The EOD is -0.303. Based on the equity, the company is expensive. -2
  • The MRQ is -0.708. Based on the equity, the company is expensive. -2
  • The TTM is -0.708. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.303MRQ-0.708+0.405
MRQ-0.708TTM-0.7080.000
TTM-0.708YOY-2.345+1.637
TTM-0.7085Y-3.499+2.791
5Y-3.49910Y-8.850+5.351
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-06-30. All numbers in thousands.

Summary
Total Assets91
Total Liabilities1,129
Total Stockholder Equity-382
 As reported
Total Liabilities 1,129
Total Stockholder Equity+ -382
Total Assets = 91

Assets

Total Assets91
Total Current Assets42
Long-term Assets49
Total Current Assets
Cash And Cash Equivalents 3
Net Receivables 27
Other Current Assets 12
Total Current Assets  (as reported)42
Total Current Assets  (calculated)42
+/-0
Long-term Assets
Property Plant Equipment 49
Long-term Assets  (as reported)49
Long-term Assets  (calculated)49
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,064
Long-term Liabilities65
Total Stockholder Equity-382
Total Current Liabilities
Short-term Debt 766
Accounts payable 205
Other Current Liabilities 93
Total Current Liabilities  (as reported)1,064
Total Current Liabilities  (calculated)1,064
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)65
Long-term Liabilities  (calculated)0
+/- 65
Total Stockholder Equity
Common Stock33,125
Retained Earnings -38,102
Accumulated Other Comprehensive Income 101
Other Stockholders Equity 4,494
Total Stockholder Equity (as reported)-382
Total Stockholder Equity (calculated)-382
+/-0
Other
Cash and Short Term Investments 3
Common Stock Shares Outstanding 209,956
Liabilities and Stockholders Equity 91
Net Debt 811
Net Working Capital -1,022
Short Long Term Debt Total 814



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
9,645
6,931
4,632
2,210
603
603
124
165
124
100
100
93
1,128
523
261
122
110
94
102
79
125
134
131
91
9113113412579102941101222615231,128931001001241651246036032,2104,6326,9319,645
   > Total Current Assets 
9,182
6,380
4,077
2,030
486
486
71
38
71
51
51
52
1,126
523
261
72
110
94
102
79
49
67
68
42
426867497910294110722615231,1265251517138714864862,0304,0776,3809,182
       Cash And Cash Equivalents 
8,654
2,355
832
957
311
311
25
9
25
12
12
24
239
48
98
18
70
57
21
27
15
30
30
3
330301527215770189848239241212259253113119578322,3558,654
       Short-term Investments 
0
3,464
2,559
799
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000007992,5593,4640
       Net Receivables 
233
129
299
183
133
133
17
4
17
5
5
0
872
432
98
17
10
10
58
42
20
25
13
27
2713252042581010179843287205517417133133183299129233
       Inventory 
80
70
52
0
0
7
15
7
15
30
30
16
0
-432
-94
-17
-10
-10
0
0
0
0
0
0
000000-10-10-17-94-432016303015715700527080
       Other Current Assets 
216
363
334
91
43
43
15
17
15
4
4
12
16
475
159
54
40
36
23
9
13
12
12
12
12121213923364054159475161244151715434391334363216
   > Long-term Assets 
464
551
555
180
117
117
53
127
53
49
49
41
1
0
0
50
0
0
0
0
77
67
63
49
496367770000500014149495312753117117180555551464
       Property Plant Equipment 
417
514
510
160
101
101
12
34
12
3
3
1
1
0
0
0
0
0
0
0
77
67
63
49
4963677700000001133123412101101160510514417
       Intangible Assets 
46
37
45
20
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001120453746
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
0
0000000050000000000000000
> Total Liabilities 
330
289
567
126
86
86
508
165
508
401
401
276
168
227
253
462
358
354
453
671
855
1,009
1,026
1,129
1,1291,0261,0098556714533543584622532271682764014015081655088686126567289330
   > Total Current Liabilities 
330
289
567
126
86
86
508
165
508
401
401
276
168
227
253
462
358
354
453
671
791
955
936
1,064
1,0649369557916714533543584622532271682764014015081655088686126567289330
       Short-term Debt 
0
0
0
0
0
0
0
0
135
0
0
0
0
20
0
198
149
153
244
478
641
777
735
766
766735777641478244153149198020000013500000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
149
153
244
478
619
753
719
0
07197536194782441531490000000000000000
       Accounts payable 
230
289
567
126
86
86
0
0
0
117
117
33
14
172
189
143
200
189
190
164
119
127
128
205
20512812711916419018920014318917214331171170008686126567289230
       Other Current Liabilities 
100
0
0
0
0
165
508
165
508
283
283
242
154
35
64
122
8
12
19
28
31
50
72
93
93725031281912812264351542422832835081655081650000100
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
643
64
55
90
65
659055646430000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
0
0000000050000000000000000
> Total Stockholder Equity
9,315
6,642
4,065
2,084
517
517
-384
0
-384
-301
-301
-114
1,158
663
517
224
340
348
271
49
-83
-224
-239
-382
-382-239-224-83492713483402245176631,158-114-301-301-3840-3845175172,0844,0656,6429,315
   Common Stock
18,526
18,306
18,345
18,345
18,345
18,345
18,969
18,746
18,969
0
0
22,379
28,590
30,316
31,561
31,933
32,393
32,710
32,864
32,967
33,028
33,088
33,125
33,125
33,12533,12533,08833,02832,96732,86432,71032,39331,93331,56130,31628,59022,3790018,96918,74618,96918,34518,34518,34518,34518,30618,526
   Retained Earnings -38,102-37,955-37,895-37,696-37,504-37,180-36,978-36,669-36,161-35,456-34,027-31,932-26,913-25,940-25,940-21,765-21,033-21,765-20,329-20,329-18,754-16,444-11,646-7,648
   Accumulated Other Comprehensive Income 
-1,567
-1,018
163
493
-878
501
0
383
453
-1,232
-560
-216
-102
93
130
170
123
122
93
91
92
90
97
101
101979092919312212317013093-102-216-560-1,2324533830501-878493163-1,018-1,567
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue93
Cost of Revenue-0
Gross Profit9393
 
Operating Income (+$)
Gross Profit93
Operating Expense-181
Operating Income-88-88
 
Operating Expense (+$)
Research Development5
Selling General Administrative176
Selling And Marketing Expenses0
Operating Expense181181
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-88
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-148-28
EBIT - interestExpense = -88
-148
-148
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-88-148
Earnings Before Interest and Taxes (EBITDA)-88
 
After tax Income (+$)
Income Before Tax-148
Tax Provision-0
Net Income From Continuing Ops0-148
Net Income-148
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses181
Total Other Income/Expenses Net-600
 

Technical Analysis of Sangui Biotech International Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sangui Biotech International Inc. The general trend of Sangui Biotech International Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sangui Biotech International Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sangui Biotech International Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0015 < 0.0015 < 0.0015.

The bearish price targets are: 0.0015 > 0.0015 > 0.0015.

Tweet this
Sangui Biotech International Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sangui Biotech International Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sangui Biotech International Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Moving Average Convergence/Divergence (MACD) ChartSangui Biotech International Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sangui Biotech International Inc. The current adx is .

Sangui Biotech International Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Relative Strength Index (RSI) ChartSangui Biotech International Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Stochastic Oscillator ChartSangui Biotech International Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Commodity Channel Index (CCI) ChartSangui Biotech International Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Chande Momentum Oscillator (CMO) ChartSangui Biotech International Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Williams %R ChartSangui Biotech International Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Average True Range (ATR) ChartSangui Biotech International Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily On-Balance Volume (OBV) ChartSangui Biotech International Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sangui Biotech International Inc.

Sangui Biotech International Inc Daily Money Flow Index (MFI) ChartSangui Biotech International Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sangui Biotech International Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Sangui Biotech International Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sangui Biotech International Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.002
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sangui Biotech International Inc with someone you think should read this too:
  • Are you bullish or bearish on Sangui Biotech International Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sangui Biotech International Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sangui Biotech International Inc

I send you an email if I find something interesting about Sangui Biotech International Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Sangui Biotech International Inc.

Receive notifications about Sangui Biotech International Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.